Correlation Between Aceragen and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Aceragen and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aceragen and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aceragen and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Aceragen and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aceragen with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aceragen and Acrivon Therapeutics,.
Diversification Opportunities for Aceragen and Acrivon Therapeutics,
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aceragen and Acrivon is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Aceragen and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Aceragen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aceragen are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Aceragen i.e., Aceragen and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Aceragen and Acrivon Therapeutics,
Given the investment horizon of 90 days Aceragen is expected to under-perform the Acrivon Therapeutics,. In addition to that, Aceragen is 1.8 times more volatile than Acrivon Therapeutics, Common. It trades about -0.06 of its total potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.01 per unit of volatility. If you would invest 1,259 in Acrivon Therapeutics, Common on September 3, 2024 and sell it today you would lose (501.00) from holding Acrivon Therapeutics, Common or give up 39.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 30.91% |
| Values | Daily Returns |
Aceragen vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Aceragen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Acrivon Therapeutics, |
Aceragen and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aceragen and Acrivon Therapeutics,
The main advantage of trading using opposite Aceragen and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aceragen position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Aceragen vs. Addex Therapeutics | Aceragen vs. Soligenix | Aceragen vs. Avenue Therapeutics | Aceragen vs. Akari Therapeutics PLC |
| Acrivon Therapeutics, vs. DiaMedica Therapeutics | Acrivon Therapeutics, vs. Lyra Therapeutics | Acrivon Therapeutics, vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |